Symbicort brought in worldwide sales of $2.7 billion last year, with $1.1 billion of that coming from the US market, where an authorised generic sold under license from AZ has been available since ...

The company’s strategy for global markets is different from the India market and is not solely based on leveraging ...

Tezepelumab demonstrated clinically relevant benefits in specific inflammatory subtypes of COPD - an historically underserved market.

A US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper competition for the ageing blockbuster. The US District Court for the Northern District of West ...

AstraZeneca chalks up double win for novel combo of asthma rescue inhaler AZ's top R&I drugs last year were asthma and chronic obstructive pulmonary disorder (COPD) inhaler Symbicort and biologic ...

Among the medications that could be negotiable are blood thinner Xarelto (Januvia) which is used for Type 2 diabetes and Symbicort, an inhaler to treat Asthma and Chronic obstructive pulmonary ...

Trust Specialists Hospital, in partnership with AstraZeneca, has marked World Asthma Day 2025 with a renewed commitment to asthma care. Under the theme ‘Make inhaled treatment accessible to all ...

The dose in mcg for each drug differs. The dosages for Breztri Aerosphere and Symbicort are usually 2 puffs twice daily. The dosage for Trelegy Ellipta is usually 1 puff once daily. Your doctor ...

Under the theme ‘Make inhaled treatment accessible to all’, the event highlighted the critical role of symbicort, a combination of formoterol and budesonide which is now covered under Ghana’s National ...